vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and AVINO SILVER & GOLD MINES LTD (ASM). Click either name above to swap in a different company.

AVINO SILVER & GOLD MINES LTD is the larger business by last-quarter revenue ($21.0M vs $19.2M, roughly 1.1× Apyx Medical Corp). AVINO SILVER & GOLD MINES LTD runs the higher net margin — 36.6% vs -6.8%, a 43.4% gap on every dollar of revenue. On growth, AVINO SILVER & GOLD MINES LTD posted the faster year-over-year revenue change (44.0% vs 34.7%). Over the past eight quarters, AVINO SILVER & GOLD MINES LTD's revenue compounded faster (51.1% CAGR vs 36.8%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Avino Silver & Gold Mines Ltd is a Canada-based mining company engaged in the exploration, development, and production of precious and base metals, primarily silver, gold, and copper. It operates its flagship Avino Mine property in Durango, Mexico, with its metal products supplied to global industrial and commodity markets.

APYX vs ASM — Head-to-Head

Bigger by revenue
ASM
ASM
1.1× larger
ASM
$21.0M
$19.2M
APYX
Growing faster (revenue YoY)
ASM
ASM
+9.2% gap
ASM
44.0%
34.7%
APYX
Higher net margin
ASM
ASM
43.4% more per $
ASM
36.6%
-6.8%
APYX
Faster 2-yr revenue CAGR
ASM
ASM
Annualised
ASM
51.1%
36.8%
APYX

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
APYX
APYX
ASM
ASM
Revenue
$19.2M
$21.0M
Net Profit
$-1.3M
$7.7M
Gross Margin
62.6%
47.1%
Operating Margin
0.1%
Net Margin
-6.8%
36.6%
Revenue YoY
34.7%
44.0%
Net Profit YoY
71.9%
558.9%
EPS (diluted)
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
ASM
ASM
Q4 25
$19.2M
Q3 25
$12.9M
$21.0M
Q2 25
$11.4M
$21.8M
Q1 25
$9.4M
$18.8M
Q4 24
$14.2M
Q3 24
$11.5M
$14.6M
Q2 24
$12.1M
$14.8M
Q1 24
$10.2M
$12.4M
Net Profit
APYX
APYX
ASM
ASM
Q4 25
$-1.3M
Q3 25
$-2.0M
$7.7M
Q2 25
$-3.8M
$2.9M
Q1 25
$-4.2M
$5.6M
Q4 24
$-4.6M
Q3 24
$-4.7M
$1.2M
Q2 24
$-6.6M
$1.2M
Q1 24
$-7.6M
$599.0K
Gross Margin
APYX
APYX
ASM
ASM
Q4 25
62.6%
Q3 25
64.4%
47.1%
Q2 25
62.3%
46.9%
Q1 25
60.1%
56.1%
Q4 24
63.0%
Q3 24
60.5%
39.1%
Q2 24
61.7%
31.8%
Q1 24
58.1%
18.9%
Operating Margin
APYX
APYX
ASM
ASM
Q4 25
0.1%
Q3 25
-6.5%
Q2 25
-22.6%
Q1 25
-32.4%
Q4 24
-21.4%
Q3 24
-31.6%
Q2 24
-45.7%
Q1 24
-64.6%
Net Margin
APYX
APYX
ASM
ASM
Q4 25
-6.8%
Q3 25
-15.4%
36.6%
Q2 25
-33.2%
13.1%
Q1 25
-44.0%
29.8%
Q4 24
-32.5%
Q3 24
-40.9%
8.0%
Q2 24
-54.0%
8.4%
Q1 24
-74.0%
4.8%
EPS (diluted)
APYX
APYX
ASM
ASM
Q4 25
Q3 25
$0.05
Q2 25
$0.02
Q1 25
$0.04
Q4 24
Q3 24
$0.01
Q2 24
$-0.19
$0.01
Q1 24
$-0.22
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
ASM
ASM
Cash + ST InvestmentsLiquidity on hand
$31.7M
$57.3M
Total DebtLower is stronger
$37.5M
Stockholders' EquityBook value
$14.5M
$182.1M
Total Assets
$66.8M
$221.9M
Debt / EquityLower = less leverage
2.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
ASM
ASM
Q4 25
$31.7M
Q3 25
$25.1M
$57.3M
Q2 25
$29.3M
$37.3M
Q1 25
$31.0M
$26.6M
Q4 24
$31.7M
Q3 24
$28.0M
$7.8M
Q2 24
$32.7M
$5.3M
Q1 24
$37.3M
$3.5M
Total Debt
APYX
APYX
ASM
ASM
Q4 25
$37.5M
Q3 25
$37.5M
Q2 25
$37.5M
Q1 25
$37.5M
Q4 24
$37.5M
Q3 24
$37.5M
Q2 24
Q1 24
Stockholders' Equity
APYX
APYX
ASM
ASM
Q4 25
$14.5M
Q3 25
$5.8M
$182.1M
Q2 25
$7.3M
$144.8M
Q1 25
$10.5M
$132.3M
Q4 24
$14.2M
Q3 24
$11.0M
$114.5M
Q2 24
$14.7M
$112.2M
Q1 24
$20.3M
$107.8M
Total Assets
APYX
APYX
ASM
ASM
Q4 25
$66.8M
Q3 25
$57.4M
$221.9M
Q2 25
$58.2M
$174.7M
Q1 25
$60.2M
$157.7M
Q4 24
$64.8M
Q3 24
$60.7M
$135.4M
Q2 24
$65.4M
$133.7M
Q1 24
$70.7M
$128.6M
Debt / Equity
APYX
APYX
ASM
ASM
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
Q4 24
2.64×
Q3 24
3.40×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
ASM
ASM
Operating Cash FlowLast quarter
$-2.5M
$8.3M
Free Cash FlowOCF − Capex
$-2.8M
FCF MarginFCF / Revenue
-14.6%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
1.08×
TTM Free Cash FlowTrailing 4 quarters
$-9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
ASM
ASM
Q4 25
$-2.5M
Q3 25
$-3.5M
$8.3M
Q2 25
$-1.2M
$8.3M
Q1 25
$-702.0K
$758.0K
Q4 24
$-2.9M
Q3 24
$-4.4M
$4.1M
Q2 24
$-4.3M
$1.1M
Q1 24
$-6.3M
$2.3M
Free Cash Flow
APYX
APYX
ASM
ASM
Q4 25
$-2.8M
Q3 25
$-4.1M
Q2 25
$-1.5M
Q1 25
$-757.0K
Q4 24
$-3.2M
Q3 24
$-4.6M
Q2 24
$-4.6M
Q1 24
$-6.4M
FCF Margin
APYX
APYX
ASM
ASM
Q4 25
-14.6%
Q3 25
-31.5%
Q2 25
-13.2%
Q1 25
-8.0%
Q4 24
-22.4%
Q3 24
-40.0%
Q2 24
-38.0%
Q1 24
-62.2%
Capex Intensity
APYX
APYX
ASM
ASM
Q4 25
1.4%
Q3 25
4.0%
Q2 25
2.3%
Q1 25
0.6%
Q4 24
1.7%
Q3 24
1.3%
Q2 24
2.4%
Q1 24
0.3%
Cash Conversion
APYX
APYX
ASM
ASM
Q4 25
Q3 25
1.08×
Q2 25
2.92×
Q1 25
0.13×
Q4 24
Q3 24
3.55×
Q2 24
0.87×
Q1 24
3.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons